A: It can reflect increased training capacity, glycogen/water shifts, appetite changes, or lean mass gain rather than pure fat gain
While ongoing research underscores its potential as a breakthrough in regenerative therapy, further human trials are essential to fully elucidate its long-term safety, efficacy, and clinical applications.
This pentadecapeptide demonstrates resistance to degradation in gastric juice, a property that distinguishes it from many therapeutic peptides that require modified administration routes to avoid gastric inactivation
Factors such as convenience, cost savings, potential digestive absorption issues, and comfort with self-administering injections can influence patients preferences
Pregnant or breastfeeding patients should discuss B12/Mic use with their obstetrician, as safety data are limited in these populations